Neuropace (NPCE) traded down -1.75 % during a 24 hours period ending at 12:00 AM Central Europe on Tuesday 27th. One Neuropace stock can currently be bought for about USD 12.99 on popular exchanges. Current supply of Neuropace stocks is 34.3 mn. Neuropace has a current market capitalization of USD 443.1 mn and approximately USD 892.1 k worth of Neuropace was traded on exchanges in the last 24 hours. Since last month end, Neuropace has traded -7.59 % down. Simple moving average of last 200 days is at USD 15.08. The highest price of past 52 weeks was recorded at USD 19.6 on 05/08/2026. 52 weeks low was at USD 9.22 on 11/03/2025.
Here is how related stocks have performed in the past 24 hours:
Northrim (NRIM) traded down -1.4 % and now trades at USD 23.74. Northrim has a market capitalisation of USD 530.8 mn. Current price/earnings ratio for Northrim is 9.68.
Onterris (ONT) traded up 1.3 % and now trades at USD 14.87. Current market capitalisation for Onterris is USD 520.8 mn.
Hallador Energy (HNRG) traded down -1.52 % and now trades at USD 10.99. Current market capitalisation for Hallador Energy is USD 520.9 mn.
Wabash National (WNC) traded down -1.76 % and now trades at USD 12.97. Current market capitalisation for Wabash National is USD 524.3 mn.
Bankwell (BWFG) traded up 0.25 % and now trades at USD 67.22. Bankwell has a market capitalisation of USD 522.1 mn. Current price/earnings ratio for Bankwell is 12.49.
About Neuropace
NeuroPace, Inc. is a commercial-stage medical device company based in Mountain View, United States. The company specializes in designing, developing, manufacturing, and marketing implantable devices for the treatment of neurological disorders with responsive stimulation. Through its cutting-edge technology, NeuroPace serves patients worldwide. You can learn more about their offerings by visiting their website at www.neuropace.com . The company’s stock is traded on the Nasdaq.